Clinical Trial Update: Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin and Soft Tissue Infections in the Emergency Department [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing oral moxifloxacin to cefazolin with oral probenecid for treating cellulitis in the emergency department has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cellulitis

Drugs mentioned

• CEFAZOLIN (cefazolin sodium)
• Moxifloxacin (moxifloxacin)
• Probenecid (probenecid)

Snippet

Sponsor: University of British Columbia | Conditions: Cellulitis | Phase 3 | Status: COMPLETED